COMMUNIQUÉS West-GlobeNewswire

Revive Therapeutics Announces Results for the Three and Nine Months Ended March 31, 2018
30/05/2018
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE:RVV) (OTCQB:RVVTF), a company focused on the research, development and commercialization of novel [...]
IMV Leadership to Participate in Upcoming Investor and Business Development Conferences
30/05/2018
HALIFAX, Nova Scotia, May 30, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX: IMV ) (OTCQX:IMMVD), a clinical stage immuno-oncology company, today announced details on upcoming industry presentations that the company’s [...]
AIT Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
30/05/2018
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients [...]
CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 for the Treatment of Sickle Cell Disease
30/05/2018
BOSTON and ZUG, Switzerland and CAMBRIDGE, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) today announced that the U.S. Food and Drug [...]
Corvus Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference
30/05/2018
BURLINGAME, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS ), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
30/05/2018
MINNEAPOLIS, May 30, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Denali Therapeutics Announces Early Exercise of Its Option to Acquire F-star Gamma
30/05/2018
SOUTH SAN FRANCISCO, May 30, 2018 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI ), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, today [...]
Medigus to Present New Data On The MUSE™ System at Digestive Disease Week® (DDW) 2018
30/05/2018
OMER, Israel, May 30, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS ) (TASE: MDGS ), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, [...]
Golden Leaf Reports Fiscal First Quarter 2018 Results
30/05/2018
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a leading cannabis oil solutions company and dispensary operator built around recognized [...]
GILEAD AND GALAPAGOS ANNOUNCE RESULTS WITH FILGOTINIB IN THE PHASE 2 EQUATOR STUDY IN PSORIATIC ARTHRITIS AND PROGRESSION INTO PHASE 3 FOR THE SELECTION STUDY IN ULCERATIVE COLITIS
30/05/2018
-- EQUATOR Achieves Primary Endpoint of ACR20 Response at Week 16 -- -- Galapagos to Receive $15 Million Payment from Gilead for Progression into Phase 3 of the Phase 2b/3 SELECTION Study of Filgotinib in Ulcerative [...]
Ascendis Pharma A/S Reports First Quarter 2018 Financial Results
30/05/2018
- Continued execution and achievement of planned milestones across three wholly-owned clinical programs in rare endocrine diseases - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, May 30, 2018 [...]
Dermira to Present at Jefferies 2018 Global Healthcare Conference
30/05/2018
MENLO PARK, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Trevena to Present at the Jefferies Global Healthcare Conference
30/05/2018
CHESTERBROOK, Pa., May 30, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that it will be presenting at the Jefferies Global Healthcare Conference on Wednesday, June 6 th , 2018, at 3:30 p.m. EDT [...]
Collegium to Present at Upcoming Investor Conferences
30/05/2018
CANTON, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) today announced that management will present at the following investor conferences in June: The Jefferies Global Healthcare [...]
Vericel Corporation Announces Proposed Public Offering of Common Stock
30/05/2018
CAMBRIDGE, Mass., May 30, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL ), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it intends to offer [...]
The Alliance for Regenerative Medicine Announces 2018 Cell & Gene Meeting on the Mesa
30/05/2018
WASHINGTON, D.C., May 30, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM), the international advocacy organization for the cell and gene therapy and broader regenerative medicine sector, announced [...]
Sedor Pharmaceuticals and Los Altos Pharmaceuticals sign license agreement for People’s Republic of China
30/05/2018
Agreement extends PRC opportunity for Sedor portfolio PAOLI, Pa. and LOS ALTOS HILLS, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Sedor Pharmaceuticals, LLC (Sedor) and Los Altos Pharmaceuticals, Inc. (Los Altos) announce [...]
Sedor Pharmaceuticals Receives Major Milestone Payment
30/05/2018
Payment from Xi’an Xintong Pharmaceutical Research Co. anchors opportunity for Sedor portfolio in People’s Republic of China PAOLI, Pa. and SHANXI, China, May 30, 2018 (GLOBE NEWSWIRE) -- Sedor Pharmaceuticals, LLC ( [...]
SuperSonic Imagine to Feature Aixplorer, the Only Ultrasound Imaging device with 510(k) Approval for Management of Liver Disease, at Digestive Disease Week 2018
30/05/2018
Attendees will experience the Aixplorer’s groundbreaking 60-second alternative to liver biopsy AIX-EN-PROVENCE, France, May 30, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company [...]

Pages